Dr. Paul Denker, MD (he/him) is an Endocrinologist in Belleair, FL with over 16 years of experience. What is your opinion of Dr. Paul Denker, MD? Rate this provider below so other people can make informed decision.
Over 16 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Paul Denker, MD has received over $20,891 which includes payments from the following companies:
$4,935.80 from Merck Sharp & Dohme Corporation
$2,358.83 from AstraZeneca Pharmaceuticals LP
$2,214.42 from Novo Nordisk Inc
$1,603.03 from sanofi-aventis U.S. LLC
$1,224.52 from GlaxoSmithKline, LLC.
$1,207.23 from LILLY USA, LLC
$1,069.11 from Pfizer Inc.
$940.79 from Janssen Pharmaceuticals, Inc
$730.62 from Boehringer Ingelheim Pharmaceuticals, Inc.
$565.67 from Amgen Inc.
$425.28 from Astellas Pharma US Inc
$345.91 from Dexcom, Inc.
$336.17 from AbbVie, Inc.
$266.99 from INSULET CORPORATION
$238.89 from Allergan Inc.
$188.48 from Salix Pharmaceuticals, a division of Bausch Health US, LLC
$180.67 from Valeritas, Inc.
$162.24 from Takeda Pharmaceuticals America, Inc.
$146.51 from Eisai Inc.
$141.35 from Corcept Therapeutics
Payments received by Dr. Paul Denker, MD were from the following categories:
$14,255.54 Food and Beverage
$4,500.00 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!